Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population. [PDF]
JAMA Dermatol, 2023 Key Points Question What is the contemporary prevalence and incidence of alopecia areata (AA), alopecia totalis, and alopecia universalis in the US? Findings In this cohort study of a nationwide US employer-sponsored insurance population, AA prevalence ...
Mostaghimi A +7 more
europepmc +3 more sources
Efficacy and safety of ritlecitinib, an oral
Journal of dermatology (Print)This post-hoc analysis of the ALLEGRO phase 2b/3 study (NCT03732807) evaluated the efficacy and safety of ritlecitinib, an oral Janus kinase 3/TEC family kinase inhibitor, in patients with alopecia totalis (AT) and alopecia universalis (AU).
Natasha Atanaskova Mesinkovska +16 more
core +4 more sources
Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis. [PDF]
Skin Res Technol, 2023 Dear Editor, Alopecia totalis (AT) is a severe form of alopecia areata (AA) that affects the entire scalp. AA treatment depends on patient age, disease phase, and disease severity, and AT usually requires aggressive systemic treatment.1 For treatment of ...
Koh YG +6 more
europepmc +4 more sources
Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection. [PDF]
JAAD Case Rep, 2022 Chidiac G +4 more
europepmc +4 more sources
JAMA Dermatol, 2023 Importance Prevalences of alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) are poorly established. Objective To estimate overall and subgroup prevalences of AA and its subtypes.
Sy N, Mastacouris N, Strunk A, Garg A.
europepmc +3 more sources
P56 Azathioprine-induced alopecia totalis and knuckle hyperpigmentation in a child with uveitis: test before you leap! [PDF]
Rheumatol Adv PractIntroduction Azathioprine is a common disease-modifying anti-rheumatic drug used in non-infectious uveitis. Although unusual, it has been associated with myelosuppression in genetically predisposed individuals who exhibit mutations in thiopurine S ...
Prabal Barman +3 more
europepmc +3 more sources
Clinical case of alopecia totalis in pediatric practice
Сучасна педіатрія: Україна, 2023 Alopecia (baldness) is a pathological hair loss. A chronic relapsing course leads to a violation of the emotional sphere of the child, worsens the quality of life.
O.А. Stroi +4 more
doaj +3 more sources
Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis. [PDF]
CureusObjectives Tofacitinib, an effective Janus kinase inhibitor (JAKi), has gained increasing interest in recent years for the management of refractory alopecia areata (AA). One of the most prevalent autoimmune diseases is AA, a kind of non-scarring alopecia.
Tirmizi SS +3 more
europepmc +3 more sources
Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study. [PDF]
Skin Appendage Disord, 2021 Background/Aim: Alopecia areata (AA) is a common autoimmune hair disorder which is characterized by noncicatricial hair loss. AA commonly presents with localized patches on the scalp and face but may affect any hair-bearing region of the body leading to ...
Uzuncakmak TK +3 more
europepmc +4 more sources
Clinical Dermatology Review, 2021 Alopecia areata (AA) is an autoimmune, nonscarring, inflammatory disorder of the scalp and/or body resulting in hair loss. Extensive AA such as alopecia totalis is increasingly unresponsive to conventional treatment modalities.
Sumit Gupta +2 more
doaj +2 more sources